Quick Summary
SEBI has confirmed restraint orders against Nirman Agri Genetics Limited and its Promoter and Managing Director, Pranav Kailas Bagal, after finding that roughly 93% of the money the company raised through its IPO may have been routed to shell entities and non-existent vendors. The company remains barred from the securities market, and its stock split, bonus issue, and name change plans stay frozen. The order, dated August 10, 2026, says the investigation is still ongoing.
If you’ve bought into an IPO expecting the money to go toward the business the company pitched you, this case is worth reading closely.
It’s a reminder of how far a company’s actual use of your money can drift from what it told you on paper.
Nirman Agri Genetics Limited, a Nashik-based agri-inputs company that makes hybrid seeds, crop protection products, and bio-organics, is now at the centre of exactly that kind of gap.
What SEBI Found After Nirman Agri Genetics IPO?
SEBI’s scrutiny started with a basic question: where did the IPO money actually go? The answer, laid out in an earlier Interim Order dated October 14, 2025, wasn’t reassuring.
SEBI’s prima facie findings pointed to roughly 93% of the IPO proceeds being diverted and siphoned out of the company.
The funds were allegedly routed through conflicting vendor profiles, entities that didn’t actually exist, and layers of shell companies, ultimately benefiting the promoter group and people connected to them.
[IMAGE: Order, Page 1, Para 2. Crop to this single paragraph describing the 93% diversion finding and the routing through shell entities. Alt text: “SEBI order paragraph describing prima facie findings that 93% of Nirman Agri Genetics’ IPO proceeds were diverted through shell entities.”]
That finding was serious enough for SEBI to move immediately, without waiting for a full investigation to wrap up first.
What Restraints Did SEBI Impose on Nirman Agri Genetics?
Based on those prima facie findings, SEBI issued three specific directions back in October 2025, and this new order confirms all three remain in effect.
Nirman Agri Genetics itself was barred from accessing the securities market in any manner until further orders.
The company was also told to halt three planned corporate actions: a bonus issue, a stock split, and a proposed name change.
Separately, Pranav Kailas Bagal, the company’s Promoter and Managing Director, was personally restrained from buying, selling, or dealing in the company’s shares in any way, directly or indirectly.
These aren’t final penalties. They’re protective measures meant to freeze the situation while SEBI digs deeper.
What Bagal Told SEBI in His Defence?
The company and Bagal were given a chance to respond.
They didn’t file written submissions for months, and when their representatives finally appeared before SEBI in July 2026, after seeking multiple extensions, their case rested on two arguments.
First, they said some of the diverted funds had already been returned to the company’s account. Second, they argued the company’s financials showed it was profitable, and asked SEBI to let the stock split, bonus issue, and name change go ahead anyway.
They then asked for two more weeks to submit written proof. SEBI gave them that time. The proof never arrived.
Why SEBI Rejected Nirman Agri Genetics’ Defence?
SEBI’s response to both arguments is the part of this order worth paying close attention to, especially if you’re evaluating any company’s claims about its own financial health.
On the claim that funds were returned, SEBI noted that no evidence was ever submitted to back it up.
And even if some money did come back, that doesn’t undo the fact that public funds were routed through fictitious and layered entities in the first place.
On the “profitable company” argument, SEBI went further.
It found that the company’s publicly reported financials didn’t present a true picture at all, since large sums had been booked as unverified “advances for purchases,” a category that let money leave the books without a clear trail.
SEBI’s view was blunt: profits built on misstated or manipulated entries can’t be used to justify regulatory relief.
Why the Stock Split and Name Change Stayed Frozen?
This is the detail that matters most if you’re a retail trader watching this stock.
SEBI specifically flagged that a stock split and bonus issue can artificially boost a share’s liquidity and float, making it look more active and attractive to new buyers.
Combined with a proposed name change, SEBI said these moves appeared designed to draw in retail investor participation, right while the company was under investigation for serious fraud.
Allowing that to go ahead risked pulling in more unsuspecting buyers before the investigation concluded.
That’s a pattern worth remembering on its own.
A stock split or bonus issue can look like good news on the surface, but it doesn’t tell you anything about whether the company’s actual finances are sound.
What Is the Current Status of Nirman Agri Genetics?
SEBI has confirmed all three original restraints, and they remain in force with immediate effect until further orders.
Importantly, SEBI was clear that these findings are still tentative, and the detailed investigation is ongoing and will proceed independently of what’s been observed so far.
This isn’t the end of the case.
It’s confirmation that SEBI still sees enough of a threat to keep the company frozen while it finishes the deeper investigation.
What Should Nirman Agri Genetics Shareholders Do Now?
If you already hold Nirman Agri Genetics shares, the company itself is currently barred from the securities market, and neither the stock split nor the bonus issue nor the name change is going ahead anytime soon.
Any of these announcements you might come across should be read against this order, not treated as confirmed.
If you’re considering buying in hoping to benefit from a stock split or bonus issue, this is exactly the kind of situation those corporate actions are meant to look attractive in.
SEBI itself flagged that concern directly in this order.
Before evaluating any IPO, it helps to know the broader patterns fraud like this tends to follow. Our guide on how IPO scams actually work covers the general warning signs.
We’ve covered a similar pattern before in the Trafiksol IPO case, where SEBI stepped in before a company’s shares even got listed.
If you want to understand how a listed company’s reported profits can hide fund diversion, our DB Realty SEBI Penalty blog walks through a comparable case.
Also Read: Your Trade Records Aren’t With SEBI. Here’s Why?
Conclusion
Ninety-three percent of a company’s own IPO money is gone, and that’s before SEBI’s deeper investigation even wraps up.
The company stays barred from the market, the promoter can’t touch his own shares, and every corporate action that could have drawn in new retail buyers has been blocked.
Neither the “funds were returned” nor the “we’re profitable” defence held up under scrutiny.
If you’re holding this stock, or eyeing it for a split or bonus issue, treat every announcement with real caution until SEBI’s deeper investigation actually concludes.
Report. Recover. Stay Fraud Free.
Not yet as a final finding. SEBI's own order describes this as a strong prima facie case pending detailed investigation, though the order does use the word "fraud" in describing the case against the company. The company itself is restrained from accessing the securities market until further orders, so check the latest exchange notices before assuming normal trading is available. No. SEBI has specifically blocked these corporate actions, along with a proposed company name change, until the investigation concludes. The company claimed some funds were returned, but SEBI found no evidence was submitted to support that claim. SEBI found the reported profits relied on unverified accounting entries booked as "advances for purchases," which it said couldn't be treated as genuine financial health. SEBI has said a detailed investigation is ongoing and will determine what final action, if any, follows. This confirmatory order only keeps the interim restraints in place. You can track SEBI's official orders section on its website, or the exchange's corporate announcements page for the specific company.Frequently Asked Questions
Add us as a preferred source on Google »
